Hyperdiluted Triamcinolone Injections for Nasal and Alar Contouring

Twenty adult patients underwent a standardized 10-point microinjection protocol using hyperdiluted TAC (approximately 1.3 mg/mL), with 1.0 mL administered per session and sessions repeated every 3 weeks for a total of five sessions. The cumulative TAC dose per patient was approximately 6.5 mg. Outcomes were assessed using patient-reported GAIS at final follow-up. This manuscript provides a patient-level GAIS reporting framework and an illustrative results table to support transparent outcome documentation. The technique is conceptually distinct from surgical rhinoplasty and filler-based approaches, aiming for gradual, localized soft-tissue thinning through dose-minimized, distributed corticosteroid exposure.